GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » United Health Products Inc (OTCPK:UEEC) » Definitions » Long-Term Debt & Capital Lease Obligation

United Health Products (United Health Products) Long-Term Debt & Capital Lease Obligation : $0.04 Mil (As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is United Health Products Long-Term Debt & Capital Lease Obligation?

Long-Term Debt & Capital Lease Obligation is the debt and capital lease obligation due more than 12 months in the future. United Health Products's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $0.04 Mil.

LT-Debt-to-Total-Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligation divides by its Total Assets. United Health Products's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $0.04 Mil. United Health Products's Total Assets for the quarter that ended in Mar. 2024 was $0.23 Mil. United Health Products's LT-Debt-to-Total-Asset for the quarter that ended in Mar. 2024 was 0.17.

United Health Products's LT-Debt-to-Total-Asset increased from Mar. 2023 (0.00) to Mar. 2024 (0.17). It may suggest that United Health Products is progressively becoming more dependent on debt to grow their business.


United Health Products Long-Term Debt & Capital Lease Obligation Historical Data

The historical data trend for United Health Products's Long-Term Debt & Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

United Health Products Long-Term Debt & Capital Lease Obligation Chart

United Health Products Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Long-Term Debt & Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 0.05

United Health Products Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Long-Term Debt & Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.07 0.06 0.05 0.04

United Health Products Long-Term Debt & Capital Lease Obligation Calculation

Long-Term Debt is the debt due more than 12 months in the future. The debt can be owed to banks or bondholders. Some companies issue bonds to investors and pay interest on the bonds.

Long-Term Capital Lease Obligation represents the total liability for long-term leases lasting over one year. It's amount equal to the present value (the principal) at the beginning of the lease term less lease payments during the lease term.

The interest paid on companies' debt is reflected in the income statement as interest expense. If a company has too much debt and it cannot serve the interest payment on the debt or repay the matured debt, the company risks bankruptcy. Peter Lynch famously said: A company that does not have debt cannot go bankrupt.

A company's long term debt may have different dates of maturity and interest rates, depending on the terms.

Usually a company issues long term debt to pay for its capital expenditures. Borrowing allows the company to do things that otherwise cannot be done with only the capital it has. But debt can be risky.


United Health Products  (OTCPK:UEEC) Long-Term Debt & Capital Lease Obligation Explanation

LT-Debt-to-Total-Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

United Health Products's LT-Debt-to-Total-Asset ratio for the quarter that ended in Mar. 2024 is calculated as:

LT-Debt-to-Total-Asset (Q: Mar. 2024 )=Long-Term Debt & Capital Lease Obligation (Q: Mar. 2024 )/Total Assets (Q: Mar. 2024 )
=0.04/0.233
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Buffett says that durable competitive advantages carry little to no long-term debt because the company is so profitable that even expansions or acquisitions are self financed.

We are interested in long term debt load for the last ten years. If the ten years of operation show little to no long term debt, then the company has some kind of strong competitive advantage.

Warren Buffett's historic purchases indicate that on any given year, the company should have sufficient yearly net earnings to pay all long term within 3 or 4 year earnings period. (e.g. Coke + Moody's = 1yr)

Companies with enough earning power to pay long term debt in less than 3 or 4 years is a good candidate in our search for long term competitive advantage.

BUT, these companies are targets for leveraged buy outs, which saddles the business with long term debt.

If all else indicates the company has a moat, but it has ton of debt, a leveraged buyout may have created the debt. In these cases the company's bonds offer the better bet, in that the company’s earnings power is focused on paying off the debt and not growth.

Important: little or no long term debt often means a Good Long Term Bet


United Health Products Long-Term Debt & Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of United Health Products's Long-Term Debt & Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


United Health Products (United Health Products) Business Description

Traded in Other Exchanges
N/A
Address
526 Commerce Circle, Suite No. 120, Mesquite, NV, USA, 89027
United Health Products Inc is a US-based company. It mainly manufactures and markets a patented hemostatic gauze for the healthcare and wound care sectors. The company's product HemoStyp is derived from regenerated oxidized cellulose, which is naturally designed to absorb exudate from superficial wounds and helps control bleeding. It markets its product to dental and medical markets as well as, sports, military and veterinary sectors, and others. The company's trademarks include Boo Boo Strips; The Ultimate Bandage; Hemostrips; CelluSTAT and Nik Fix.
Executives
Brian David Thom officer: CEO 10624 S EASTERN AVE., STE A209, HENDERSON NV 89052
Kristofer Heaton officer: Vice-President Finance, CFO 526 COMMERCE CIRCLE, STE 120, MESQUITE NV 89027
Nate Knight director C/O MORSE & MORSE, PLLC, 1400 OLD COUNTRY ROAD, SUITE 302, WESTBURY NY 11590
Louis Schiliro officer: Chief Operating Officer 10624 S. EASTERN AVENUE, STE. A209, HENDERSON NV 89052
Douglas K Beplate officer: CEO
Robert J. Denser director 10624 S. EASTERN AVE., STE. A209, HENDERSON NV 89052
John Vito Capotorto director 1090 KING GEORGES POST ROAD, SUITE 501, EDISON NJ 08837
Sherman Lazrus director
Rodney Paul Leibowitz director 420 EAST 54TH STREET, APARTMENT 15B, NEW YORK NY 10022
Michael R. Wiechnik director 11 PRESWICK DR., MEDFORD NJ 08055
Richard Rifenburgh director 2637 E. ATLANTIC BLVD., #133, POMPANO BEACH FL 33062
Phillip David Forman director, officer: President, Chairman and CEO 1090 KING GEORGES POST RD,501, EDISON NJ 08837
Jan E Chason director, officer: Chief Financial Officer 120 WALL STREET, SUITE 2401, NEW YORK NY 10005
Kelly Thomas Hickel director, officer: Chief Executive Officer 1630A 30TH STREET, SUITE 300, BOULDER CO 80301
Patrick Donelan 10 percent owner 3570 LAKEVIEW DRIVE, DELRAY BEACH FL 33445